FIBRYGA: payments to doctors
Payments that named FIBRYGA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.5M
- Providers
- 2,608
- Transactions
- 3,761
- Average per transaction
- $670
The per-transaction average — $670 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,608 providers the average total is $966, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Octapharma USA, Inc. | $2,519,089 | 100.0% |